PT2950783T - Lágrimas artificiais compreendendo hialuronato de sódio e carboximetilcelulose - Google Patents

Lágrimas artificiais compreendendo hialuronato de sódio e carboximetilcelulose

Info

Publication number: PT2950783T
Authority: PT; Portugal
Prior art keywords: carboxymethylcellulose; sodium hyaluronate; artificial tears; tears; artificial
Prior art date: 2013-02-01

Application number

PT14704747T

Other languages

English (en)

Inventor

G Vehige Joseph

M Blanda Wendy

A Simmons Peter

J Beard Bereth

A Marsh David

Haixia Liu

S Matsumoto Steven

Original Assignee

Allergan Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-02-01

Filing date

2014-02-03

Publication date

2019-08-21

2014-02-03 Application filed by Allergan Inc filed Critical Allergan Inc

2019-08-21 Publication of PT2950783T publication Critical patent/PT2950783T/pt

Links

229920002385 Sodium hyaluronate Polymers 0.000 title 1
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 title 1
239000000607 artificial tear Substances 0.000 title 1
235000010948 carboxy methyl cellulose Nutrition 0.000 title 1
239000001768 carboxy methyl cellulose Substances 0.000 title 1
239000008112 carboxymethyl-cellulose Substances 0.000 title 1
229920001027 sodium carboxymethylcellulose Polymers 0.000 title 1
229940010747 sodium hyaluronate Drugs 0.000 title 1
YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Ophthalmology & Optometry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Dispersion Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

PT14704747T 2013-02-01 2014-02-03 Lágrimas artificiais compreendendo hialuronato de sódio e carboximetilcelulose PT2950783T (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201361759710P	2013-02-01	2013-02-01
US201361785857P	2013-03-14	2013-03-14

Publications (1)

Publication Number	Publication Date
PT2950783T true PT2950783T (pt)	2019-08-21

Family

ID=50113045

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PT191513597T PT3517100T (pt)	2013-02-01	2014-02-03	Lágrimas artificiais compreendendo hialuronato de sódio e carboximetilcelulose
PT14704747T PT2950783T (pt)	2013-02-01	2014-02-03	Lágrimas artificiais compreendendo hialuronato de sódio e carboximetilcelulose

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PT191513597T PT3517100T (pt)	2013-02-01	2014-02-03	Lágrimas artificiais compreendendo hialuronato de sódio e carboximetilcelulose

Country Status (24)

Country	Link
US (3)	US20140221309A1 (pt)
EP (2)	EP2950783B1 (pt)
JP (2)	JP6527468B2 (pt)
KR (1)	KR102227202B1 (pt)
CN (2)	CN111419794A (pt)
AU (2)	AU2014212025A1 (pt)
BR (1)	BR112015018414B1 (pt)
CA (1)	CA2898217C (pt)
CY (1)	CY1124054T1 (pt)
DK (2)	DK3517100T3 (pt)
ES (2)	ES2741141T3 (pt)
HK (1)	HK1218517A1 (pt)
HR (1)	HRP20191382T1 (pt)
HU (2)	HUE044555T2 (pt)
LT (1)	LT2950783T (pt)
MX (1)	MX367461B (pt)
PL (2)	PL2950783T3 (pt)
PT (2)	PT3517100T (pt)
RS (1)	RS59271B1 (pt)
RU (1)	RU2687275C2 (pt)
SA (1)	SA517381008B1 (pt)
SI (2)	SI2950783T1 (pt)
WO (1)	WO2014121232A1 (pt)
ZA (1)	ZA201505026B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2837626T3 (es)	2013-07-10	2021-07-01	Matrix Biology Inst	Composiciones de hialuronano con alta elasticidad y usos de las mismas
US9694084B2 (en)	2014-12-23	2017-07-04	Dana-Farber Cancer Institute, Inc.	Methods to induce targeted protein degradation through bifunctional molecules
US20170014339A1 (en) *	2015-07-17	2017-01-19	i.com medical GmbH	Tear Substitute, Fluid for Being Used as a Tear Substitute, and Method for Producing a Tear Substitute
PT3352766T (pt)	2015-09-24	2022-03-22	Matrix Biology Inst	Composições de hialuronano de elevada elasticidade e processos para o seu uso
WO2017075019A1 (en) *	2015-10-28	2017-05-04	Welch David B	Eye drops
ES2621877B1 (es) *	2016-01-04	2018-05-04	Agencia Pública Empresarial Sanitaria Hospital De Poniente	Solución para resección endoscópica
US10632202B2 (en) *	2016-03-04	2020-04-28	Johnson & Johnson Consumer Inc.	Preservative containing compositions
GB201618175D0 (en) *	2016-10-27	2016-12-14	Warneford Healthcare Ltd	Pharmaceutical compositions
EP3412276A3 (de) *	2017-06-09	2019-07-17	Omnivision GmbH	Zusammensetzung zur behandlung des trockenen auges
EP3852725A4 (en) *	2018-09-20	2022-08-03	The Hong Kong University of Science and Technology	EYE DROP COMPOSITIONS
KR102051356B1 (ko) *	2019-01-03	2019-12-03	(주)휴온스	고농도의 히알루론산 또는 그의 염을 함유하는 점안 조성물
CA3212315A1 (en)	2021-03-10	2022-09-15	Bausch + Lomb Ireland Limited	Ophthalmic solutions

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5017229A (en)	1990-06-25	1991-05-21	Genzyme Corporation	Water insoluble derivatives of hyaluronic acid
US6271216B1 (en) *	1989-07-24	2001-08-07	Allergan	Stable solution of hyaluronate in a balanced salt medium
KR100730527B1 (ko) *	1999-02-19	2007-06-20	덴끼 가가꾸 고교 가부시키가이샤	히알루론산 겔 조성물과 그의 제조방법 및 그것을함유하는 의용 재료
JP2002539157A (ja)	1999-03-15	2002-11-19	トラスティーズオブボストンユニバーシティ	血管新生阻害
PL356093A1 (en) *	1999-11-09	2004-06-14	Alcon Inc.	Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders
DE60016455T2 (de) *	1999-12-17	2005-12-15	Genzyme Corp., Cambridge	Chirurgische prothese
CN1485395A (zh) *	2002-09-25	2004-03-31	宋海涛	一种环保型“冷热液”
US20040137079A1 (en) *	2003-01-08	2004-07-15	Cook James N.	Contact lens and eye drop rewetter compositions and methods
JP2006052160A (ja) *	2004-08-10	2006-02-23	Rohto Pharmaceut Co Ltd	ドライアイ治療用眼科組成物
JP2006143590A (ja) *	2004-10-21	2006-06-08	Rohto Pharmaceut Co Ltd	粘膜適用組成物
CN101056614A (zh) *	2004-11-09	2007-10-17	眼力健有限公司	眼用溶液
US8569367B2 (en) *	2004-11-16	2013-10-29	Allergan, Inc.	Ophthalmic compositions and methods for treating eyes
WO2008011836A2 (es) *	2006-07-25	2008-01-31	Osmotica Corp.	Soluciones oftálmicas
WO2008073193A2 (en) *	2006-11-06	2008-06-19	Novartis Ag	Ocular devices and methods of making and using thereof
US8609634B2 (en) *	2007-05-16	2013-12-17	Mcneil-Ppc, Inc.	Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
KR100827400B1 (ko) *	2008-06-24	2008-05-06	김정춘	파이프 연결구를 갖는 수도계량기 및 그 제조방법
KR100938500B1 (ko) *	2008-06-24	2010-01-28	주식회사 디에이치피코리아	안과질환 예방 및 치료용 점안제 조성물
US20100086512A1 (en)	2008-10-02	2010-04-08	Rolf Schaefer	Mucomimetic compositions and uses therefore
EP2349232A1 (en) *	2008-10-20	2011-08-03	Allergan, Inc.	Ophthalmic compositions useful for improving visual acuity
KR20120112537A (ko) *	2009-12-15	2012-10-11	포어사이트 바이오쎄라퓨틱스, 인코퍼레이티드	무자극성 안과용 포비돈-요오드 조성물
CN101785852A (zh) *	2010-01-21	2010-07-28	孙杰	一种真皮层微量介入美容抗衰除皱制剂与方法
CN101884602A (zh) *	2010-03-03	2010-11-17	孙杰	一种皮肤美容修复抗衰除皱的化妆品制剂

2014
- 2014-02-03 PL PL14704747T patent/PL2950783T3/pl unknown
- 2014-02-03 SI SI201431299T patent/SI2950783T1/sl unknown
- 2014-02-03 CN CN202010439040.1A patent/CN111419794A/zh active Pending
- 2014-02-03 AU AU2014212025A patent/AU2014212025A1/en not_active Abandoned
- 2014-02-03 CA CA2898217A patent/CA2898217C/en active Active
- 2014-02-03 RU RU2015132974A patent/RU2687275C2/ru active
- 2014-02-03 LT LT14704747T patent/LT2950783T/lt unknown
- 2014-02-03 ES ES14704747T patent/ES2741141T3/es active Active
- 2014-02-03 EP EP14704747.6A patent/EP2950783B1/en active Active
- 2014-02-03 PT PT191513597T patent/PT3517100T/pt unknown
- 2014-02-03 BR BR112015018414-6A patent/BR112015018414B1/pt active IP Right Grant
- 2014-02-03 KR KR1020157023645A patent/KR102227202B1/ko active IP Right Grant
- 2014-02-03 CN CN201480007049.8A patent/CN104981234A/zh active Pending
- 2014-02-03 RS RSP20190971 patent/RS59271B1/sr unknown
- 2014-02-03 PL PL19151359T patent/PL3517100T3/pl unknown
- 2014-02-03 HU HUE14704747 patent/HUE044555T2/hu unknown
- 2014-02-03 US US14/171,076 patent/US20140221309A1/en not_active Abandoned
- 2014-02-03 DK DK19151359.7T patent/DK3517100T3/da active
- 2014-02-03 DK DK14704747.6T patent/DK2950783T3/da active
- 2014-02-03 HU HUE19151359A patent/HUE052793T2/hu unknown
- 2014-02-03 JP JP2015556212A patent/JP6527468B2/ja active Active
- 2014-02-03 PT PT14704747T patent/PT2950783T/pt unknown
- 2014-02-03 EP EP19151359.7A patent/EP3517100B1/en active Active
- 2014-02-03 WO PCT/US2014/014505 patent/WO2014121232A1/en active Application Filing
- 2014-02-03 ES ES19151359T patent/ES2841434T3/es active Active
- 2014-02-03 SI SI201431728T patent/SI3517100T1/sl unknown
- 2014-02-03 MX MX2015009924A patent/MX367461B/es active IP Right Grant
2015
- 2015-07-13 ZA ZA2015/05026A patent/ZA201505026B/en unknown
- 2015-07-30 SA SA517381008A patent/SA517381008B1/ar unknown
2016
- 2016-04-27 US US15/140,291 patent/US20160235780A1/en not_active Abandoned
- 2016-06-08 HK HK16106565.4A patent/HK1218517A1/zh unknown
2018
- 2018-11-07 AU AU2018260857A patent/AU2018260857B2/en active Active
2019
- 2019-02-12 JP JP2019022506A patent/JP6876079B2/ja active Active
- 2019-07-31 HR HRP20191382 patent/HRP20191382T1/hr unknown
2020
- 2020-12-09 CY CY20201101166T patent/CY1124054T1/el unknown
2021
- 2021-08-11 US US17/399,504 patent/US20220096531A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PL3517100T3 (pl)	2021-04-19
JP6527468B2 (ja)	2019-06-05
US20160235780A1 (en)	2016-08-18
MX2015009924A (es)	2015-09-25
CA2898217A1 (en)	2014-08-07
MX367461B (es)	2019-08-21
US20220096531A1 (en)	2022-03-31
US20140221309A1 (en)	2014-08-07
BR112015018414B1 (pt)	2022-11-08
ES2741141T3 (es)	2020-02-10
SI3517100T1 (sl)	2021-02-26
CN111419794A (zh)	2020-07-17
EP3517100B1 (en)	2020-09-09
HK1218517A1 (zh)	2017-02-24
LT2950783T (lt)	2019-10-25
KR102227202B1 (ko)	2021-03-12
CN104981234A (zh)	2015-10-14
WO2014121232A1 (en)	2014-08-07
KR20150113156A (ko)	2015-10-07
EP2950783B1 (en)	2019-05-15
HUE044555T2 (hu)	2019-11-28
PL2950783T3 (pl)	2019-11-29
CY1124054T1 (el)	2022-03-24
ZA201505026B (en)	2016-07-27
DK3517100T3 (da)	2020-12-14
AU2014212025A1 (en)	2015-08-20
BR112015018414A2 (pt)	2017-07-18
HRP20191382T1 (hr)	2019-11-15
AU2018260857A1 (en)	2018-11-22
PT3517100T (pt)	2020-12-15
JP2016507529A (ja)	2016-03-10
JP2019112411A (ja)	2019-07-11
DK2950783T3 (da)	2019-07-22
CA2898217C (en)	2021-08-31
EP2950783A1 (en)	2015-12-09
SI2950783T1 (sl)	2019-10-30
RS59271B1 (sr)	2019-10-31
RU2015132974A (ru)	2017-03-06
ES2841434T3 (es)	2021-07-08
HUE052793T2 (hu)	2021-05-28
AU2018260857B2 (en)	2020-05-07
JP6876079B2 (ja)	2021-05-26
SA517381008B1 (ar)	2019-08-31
EP3517100A1 (en)	2019-07-31
RU2687275C2 (ru)	2019-05-13

Publication	Publication Date	Title
HK1218517A1 (zh)	2017-02-24	包含透明質酸鈉和羧甲基纖維素的人工淚液
HK1213961A1 (zh)	2016-07-15	鉸鏈
EP2948519A4 (en)	2016-08-17	DELAYED GELIFYING AGENTS
HK1222664A1 (zh)	2017-07-07	硫酸乙酰肝素
HK1217452A1 (zh)	2017-01-13	含有***胺的眼内植入物
EP2986798A4 (en)	2016-11-09	HINGE
HK1222572A1 (zh)	2017-07-07	包含膠原和透明質酸鈉的藥物組合物
EP2987933A4 (en)	2016-12-21	HINGE
SG11201505267SA (en)	2015-08-28	Jctvc-l0226: vps and vps_extension updates
GB201304837D0 (en)	2013-05-01	Implant trialling
GB2520480B (en)	2020-08-12	Improvements in hinge assemblies
PL2978326T4 (pl)	2021-09-20	Papierosy i ich budowa
HK1221906A1 (zh)	2017-06-16	硫酸乙酰肝素
GB201304835D0 (en)	2013-05-01	Implant trialling
GB201421052D0 (en)	2015-01-14	Artificial tissue
HK1223555A1 (zh)	2017-08-04	用於減少眼內壓的組合物和方法
GB201303796D0 (en)	2013-04-17	Condom
GB201303131D0 (en)	2013-04-10	Ocular prosthesis
GB2517211B (en)	2016-05-25	Conformable tissue expander
EP3003323A4 (en)	2016-12-28	POLYSACCARIDE COMPOSITIONS AND CORRESPONDING METHODS
ZA201407945B (en)	2019-09-25	Hinge arrangement
GB201321018D0 (en)	2014-01-15	Improvements in hinge assemblies